Literature DB >> 7670402

Presence of host-specific interleukin 2-secreting T helper cell precursors correlates closely with active primary and secondary chronic graft-versus-host disease.

D Bunjes1, M Theobald, T Nierle, R Arnold, H Heimpel.   

Abstract

We investigated the role of interleukin 2 (IL-2)-secreting T helper cell precursors (Th-p) in primary and secondary chronic graft-versus-host disease (GVHD). Twelve patients with chronic GVHD (8 primary and 4 secondary chronic GVHD) and 8 patients without chronic GVHD were investigated using a sensitive limiting dilution assay. High frequencies of host-reactive interleukin 2-secreting T helper cell precursors were detectable in all patients with chronic GVHD irrespective of the mode of onset. Host-reactive IL-2-secreting T helper cell precursors disappeared in patients whose GVHD resolved. Host-reactive IL-2-secreting T helper cell precursors were never found in the control patients without chronic GVHD. Host-reactive cytotoxic T cell precursors (CTL-p) were not consistently detectable in patients with chronic GVHD and were occasionally found in patients without GVHD. No autoreactive IL-2-secreting T helper cell precursors or cytotoxic T cell precursors were detectable in either group. The absence of autoreactive IL-2-secreting T helper cell precursors in patients was confirmed by clonal specificity analysis in 4 patients. These data suggest a role for host-reactive IL-2-secreting T helper cell precursors in the initiation and maintenance of chronic GVHD as previously shown for acute GVHD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7670402

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  4 in total

1.  Langerhans' cells are depleted in chronic graft versus host disease.

Authors:  S Aractingi; E Gluckman; M C Dauge-Geffroy; C Le Goué; A Flahaut; L Dubertret; E Carosella
Journal:  J Clin Pathol       Date:  1997-04       Impact factor: 3.411

2.  Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.

Authors:  W J Murphy; L A Welniak; D D Taub; R H Wiltrout; P A Taylor; D A Vallera; M Kopf; H Young; D L Longo; B R Blazar
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

3.  Analysis of cytokine production and V beta T-cell receptor subsets in irradiated recipients receiving portal or peripheral venous reconstitution with allogeneic bone marrow cells, with or without additional anti-cytokine monoclonal antibodies.

Authors:  R M Gorczynski; Z Chen; H Zeng; L Gorczynski; E Terzioglu
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

4.  Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality.

Authors:  Lisa K Jasperson; Christoph Bucher; Angela Panoskaltsis-Mortari; Andrew L Mellor; David H Munn; Bruce R Blazar
Journal:  Blood       Date:  2009-10-14       Impact factor: 22.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.